Exenatide and the treatment of patients with Parkinson's disease

BACKGROUND. There is increasing interest in methods to more rapidly and cost-efficiently investigate drugs that are approved for clinical use in the treatment of another condition. Exenatide is a type 2 diabetes treatment that has been shown to have neuroprotective/neurorestorative properties in pre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of clinical investigation 2013-06, Vol.123 (6), p.2730-2736
Hauptverfasser:	Aviles-Olmos, Iciar, Dickson, John, Kefalopoulou, Zinovia, Djamshidian, Atbin, Ell, Peter, Soderlund, Therese, Whitton, Peter, Wyse, Richard, Isaacs, Tom, Lees, Andrew, Limousin, Patricia, Foltynie, Thomas
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antiparkinson Agents - administration & dosage Antiparkinson Agents - adverse effects Biomedical research Clinical Medicine Complications and side effects Constipation - chemically induced Disease Progression Dosage and administration Drug Repositioning Drug therapy Exenatide Female Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - adverse effects Injections, Subcutaneous Male Middle Aged Motor Activity - drug effects Off-Label Use Parkinson Disease - drug therapy Parkinson Disease - physiopathology Parkinson's disease Peptides - administration & dosage Peptides - adverse effects Studies Venoms - administration & dosage Venoms - adverse effects Weight Loss - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!